CN Patent

CN108283626B — 一种阻断药物释放的膜及其制备

Assigned to JIANGSU CHANGTAI PHARMACEUTICAL CO Ltd · Expires 2021-02-26 · 5y expired

What this patent protects

本发明提供了一种阻断药物释放的膜的组成及其制备，该膜组份包含隔离聚合物、增塑剂和二甲硅油，还包括抗粘剂中的一种或两种。本发明与现有技术相比，具有如下技术效果：1.组分中不需添加中和电荷的表面活性剂。2.阻断药物释放能力更强。3.可降低工艺过程中因静电产生的工艺问题。

USPTO Abstract

本发明提供了一种阻断药物释放的膜的组成及其制备，该膜组份包含隔离聚合物、增塑剂和二甲硅油，还包括抗粘剂中的一种或两种。本发明与现有技术相比，具有如下技术效果：1.组分中不需添加中和电荷的表面活性剂。2.阻断药物释放能力更强。3.可降低工艺过程中因静电产生的工艺问题。

Drugs covered by this patent

chembl-chembl2103744 (MORPHINE SULFATE)

Patent Metadata

Patent number: CN108283626B
Jurisdiction: CN
Classification: —
Expires: 2021-02-26
Drug substance claim: No
Drug product claim: No
Assignee: JIANGSU CHANGTAI PHARMACEUTICAL CO Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.